Skip to content

Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19

Impact of the Double-Trunk Mask on Oxygenation Titration in Patients With COVID-19

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04346420
Enrollment
12
Registered
2020-04-15
Start date
2020-04-09
Completion date
2020-05-01
Last updated
2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID, Hypoxemia

Brief summary

This study will investigate the impact of the Double-Trunk Mask (DTM) on the reduction of oxygen titration in patients with severe hypoxemia.

Detailed description

The Double-Trunk Mask (DTM) is a device designed to increase the fraction of inspired oxygen in patients who receive oxygen therapy. The mask is composed of a regular aerosol mask with corrugated tubing (15 cm length) inserted into two lateral holes. Each included patient will wear standard nasal cannula in addition to the Double-Trunk Mask for 30 minutes, then only their standard oxygen interface for the next 30 minutes. While maintaining the oxygen saturation by pulse oximetry (SpO2) at a target value of 94%, the impact of the DTM will be assessed by measuring the change of oxygen flow given to the patient.

Interventions

The standard nasal cannula interface accompanied with the DTM is worn by the patient. Oxygen output is adapted to reach a SpO2 target of 94%.

OTHERStandard interface

The standard interface for administering oxygen (nasal cannula or oxygen mask) is worn by the patient. Oxygen output is adapted to reach a SpO2 target of 94%.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COVID-19 * SpO2 between 92 and 96% with low-flow oxygen therapy (\< 15 L/min).

Exclusion criteria

* Chronic obstructive pulmonary disease or other chronic respiratory disease * Confusion * Hypoxemia corrected (SpO2 ≥ 96%) with O2 flow ≤ 3 L/min * Contra-indications to arterial blood gas sampling (peripheral arteriopathy, bleeding disorder)

Design outcomes

Primary

MeasureTime frameDescription
Change in O2 outputAt baseline and 30 minutes after wearing both systemsThe O2 output will be adjusted to maintain a SpO2 of 94% using both systems for administering O2. The O2 flow will be read from the position of the ball in flow meters.

Secondary

MeasureTime frameDescription
Comfort with the interfaces30 minutes after wearing both systemsA Likert scale from 0 to 5 will be used to measure the subjective comfort of the patient while wearing the standard interface for administering O2 and/or the DTM
Changes in PaO2At baseline and 30 minutes after wearing DTMOxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial system
Changes in PaCO2At baseline and 30 minutes after wearing DTMCarbon dioxide tension (PaCO2) in mmHg will be analyzed from a sample taken from the arterial system.
Changes in pHAt baseline and 30 minutes after wearing DTMPotential of Hydrogen (pH) will be analyzed from a sample taken from the arterial system.
Changes in respiratory rateAt baseline and 30 minutes after wearing both systemsRespiratory rate is measured during one minute by visual inspection.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026